Sample | Title | Value | Rank |
GSM967852 | U87-EV human glioblastoma xenograft - Control 1 | 2.36393 | 14 |
GSM967853 | U87-EV human glioblastoma xenograft - Control 2 | 2.34911 | 14 |
GSM967854 | U87-EV human glioblastoma xenograft - Control 3 | 2.35036 | 14 |
GSM967855 | U87-EV human glioblastoma xenograft - Control 4 | 2.30746 | 14 |
GSM967856 | U87-EV human glioblastoma xenograft - Control 5 | 2.29995 | 14 |
GSM967862 | U87-EV human glioblastoma xenograft - Bevacizumab treated 1 | 2.40536 | 14 |
GSM967863 | U87-EV human glioblastoma xenograft - Bevacizumab treated 2 | 2.37367 | 14 |
GSM967864 | U87-EV human glioblastoma xenograft - Bevacizumab treated 3 | 2.32825 | 14 |
GSM967865 | U87-EV human glioblastoma xenograft - Bevacizumab treated 4 | 2.32778 | 14 |
GSM967857 | U87-EV human glioblastoma xenograft - dibenzazepine treated 1 | 2.33388 | 14 |
GSM967858 | U87-EV human glioblastoma xenograft - dibenzazepine treated 2 | 2.33103 | 14 |
GSM967859 | U87-EV human glioblastoma xenograft - dibenzazepine treated 3 | 2.32925 | 14 |
GSM967860 | U87-EV human glioblastoma xenograft - dibenzazepine treated 4 | 2.34008 | 14 |
GSM967861 | U87-EV human glioblastoma xenograft - dibenzazepine treated 5 | 2.34118 | 14 |